The new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences

Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure for your work.

basic biomedical research
translational biomedical research
Synthetic and Systems Biology
regenerative medicine
cancer research
drug development
cell and gene therapy
infectious disease

The only choice for your next manuscript

The things that matter to you are the things that matter to us: speed, credibility, authority, visibility, and discoverability.

Re:GEN Open is the home for your next manuscript.

Submit Your Manuscript


06 Dec 2021

Receive a response to your submission faster than the competition - our current time-to-first-decision is only 17 days!
Submit Now

Latest Articles

Dec 16, 2021
Dynamic Epigenetic Regulation of miR-10 Family Governs the Caudalization of Floor Plate Neural Progenitors
Zhangting Wang, Sin-Hang Fung, Chi-Lam Yu, Patrick Wai-Nok Law, Suyu Hao, Kai-Kei Miu, and Wai-Yee Chan
Oct 22, 2021
Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret, Melina del Papa, and María Silvia Passerini
Oct 22, 2021
The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis—A Meta-Analysis
Miao Wang, Guohui Li, Ranru Wei, Zhaojun Jia, Yao Gu, Aman Sattout, Jie Zhang, and Feng Zhao
Oct 20, 2021
Acanthamoeba Keratitis: Developing a Novel Contact Lens Disinfectant Remains an Unmet Need
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, and Naveed Ahmed Khan
Oct 19, 2021
P13K/AKT/mTOR Pathway-Based Novel Biomarkers for Breast Cancer
Varruchi Sharma, Anil Panwar, and Anil K. Sharma
Oct 14, 2021
Prime Editing, a Novel Genome-Editing Tool That May Surpass Conventional CRISPR-Cas9
Adriana Ochoa-Sanchez, Gabriela Perez-Sanchez, A. Marianna Torres-Ledesma, Juan Pablo R. Valdez, Gabriel Rinaldi, Bárbara B. Moguel, and Christian Molina-Aguilar